|
Feasibility of an induced metabolic bioluminescence imaging technique in ovarian cancer: Results of a pilot study. |
| |
|
Honoraria - AstraZeneca; MSD Oncology; PharmaMar; Roche Pharma AG |
Travel, Accommodations, Expenses - PharmaMar; Pierre Fabre |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - AstraZeneca; Celgene; Eisai; Janssen; Novartis; Pfizer; Pierre Fabre; Roche; Sividon Diagnostics; Teva |
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Janssen; Novartis; Pfizer; Pierre Fabre; Roche; Sividon Diagnostics |
Research Funding - Bayer; Sanofi |
Patents, Royalties, Other Intellectual Property - Sividon Diagnostics |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |